This is a R&D company. They have a compound collection. They are still spending huge money every year to look for novel candidates and new indications. To do screening work, they need do reference search. They need a priority list for planning and a summary list for decision makers. They have well-known doctors and scientists on the committee. Who cares a poster's list or imagination
What are they doing?, page-24
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $203.0K | 45.14M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 104 | 103311567 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31829254 | 17 |
View Market Depth
| Last trade - 10.53am 30/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |